-
公开(公告)号：US20200253757A1
公开(公告)日：2020-08-13
申请号：US16786736
申请日：2020-02-10
Applicant: Elixir Medical Corporation
Inventor： Motasim Sirhan , John Yan , Vinayak Bhat , Joseph Paraschac , Brett Cryer , Benjamyn Serna
Abstract: A stent (scaffold) or other luminal prosthesis comprising circumferential structural elements which provide high strength after deployment and allows for scaffold to uncage, and/or allow for scaffold or luminal expansion thereafter. The circumferential scaffold is typically formed from non-degradable material and will be modified to expand and/or uncage after deployment.
-
公开(公告)号：US20200093619A1
公开(公告)日：2020-03-26
申请号：US15900404
申请日：2018-02-20
Applicant: Elixir Medical Corporation
Inventor： Xiaoxia Zheng , John Yan , Vinayak Bhat
Abstract: The disclosure provides biodegradable implantable devices such as a stent comprising a biodegradable polymeric wherein the polymeric material is treated to control crystallinity and/or Tg. The stent is capable to expand at body temperature in a body lumen from a crimped configuration to a deployed diameter and have sufficient strength to support a body lumen.
-
公开(公告)号：US20190365548A1
公开(公告)日：2019-12-05
申请号：US16518657
申请日：2019-07-22
Applicant: Elixir Medical Corporation
Inventor： Motasim Sirhan , John Yan , Vinayak Bhat , Joseph Paraschac , Brett Cryer , Benjamyn Serna
Abstract: A stent (scaffold) or other luminal prosthesis comprising circumferential structural elements which provides high strength after deployment and allows for scaffold to uncage, and/or allow for scaffold or luminal expansion thereafter. The circumferential scaffold may be formed from degradable material, or may be formed from non-degradable material and will be modified to expand and/or uncage after deployment.
-
公开(公告)号：US09943426B2
公开(公告)日：2018-04-17
申请号：US15605601
申请日：2017-05-25
Applicant: Elixir Medical Corporation
Inventor： Motasim Sirhan , John Yan , Vinayak Bhat , Joseph Paraschac , Brett Cryer , Benjamyn S. Serna
CPC classification number: A61F2/89 , A61F2/2442 , A61F2/90 , A61F2/915 , A61F2002/075 , A61F2002/825 , A61F2002/91558 , A61F2002/91566 , A61F2002/91575 , A61F2002/91591 , A61F2210/0004 , A61F2210/0014 , A61F2210/0076 , A61F2220/0033 , A61F2220/0091 , A61F2230/0006 , A61F2230/0008 , A61F2230/001 , A61F2230/0069 , A61F2250/0031 , A61F2250/0036 , A61F2250/0048 , A61F2250/0067 , A61F2250/0071
Abstract: A stent (scaffold) or other luminal prosthesis comprising circumferential structural elements which provides high strength after deployment and allows for scaffold to uncage, and/or allow for scaffold or luminal expansion thereafter. The circumferential scaffold may be formed from degradable material, or may be formed from non-degradable material and will be modified to expand and/or uncage after deployment.
-
公开(公告)号：US20170290686A1
公开(公告)日：2017-10-12
申请号：US15605601
申请日：2017-05-25
Applicant: Elixir Medical Corporation
Inventor： Motasim Sirhan , John Yan , Vinayak Bhat , Joseph Paraschac , Brett Cryer , Benjamyn S. Serna
CPC classification number: A61F2/89 , A61F2/2442 , A61F2/90 , A61F2/915 , A61F2002/075 , A61F2002/825 , A61F2002/91558 , A61F2002/91566 , A61F2002/91575 , A61F2002/91591 , A61F2210/0004 , A61F2210/0014 , A61F2210/0076 , A61F2220/0033 , A61F2220/0091 , A61F2230/0006 , A61F2230/0008 , A61F2230/001 , A61F2230/0069 , A61F2250/0031 , A61F2250/0036 , A61F2250/0048 , A61F2250/0067 , A61F2250/0071
Abstract: A stent (scaffold) or other luminal prosthesis comprising circumferential structural elements which provides high strength after deployment and allows for scaffold to uncage, and/or allow for scaffold or luminal expansion thereafter. The circumferential scaffold may be formed from degradable material, or may be formed from non-degradable material and will be modified to expand and/or uncage after deployment.
-
Patent Agency Ranking
公开(公告)号：US09566371B2
公开(公告)日：2017-02-14
申请号：US14804415
申请日：2015-07-21
Applicant: Elixir Medical Corporation
Inventor： Xiaoxia Zheng , John Yan , Vinayak Bhat
CPC classification number: A61F2/915 , A61F2/82 , A61F2/90 , A61F2/91 , A61F2002/91558 , A61F2002/91566 , A61F2002/91575 , A61F2210/0004 , A61F2210/0014 , A61F2210/0019 , A61F2230/0013 , A61F2230/0069 , A61F2240/001 , A61F2250/0073 , A61L31/048 , A61L31/06 , A61L31/14 , A61L31/148 , B33Y80/00 , C08L67/04
Abstract: The disclosure provides biodegradable implantable devices such as a stent comprising a biodegradable polymeric wherein the polymeric material is treated to control crystallinity and/or Tg. The stent is capable to expand at body temperature in a body lumen from a crimped configuration to a deployed diameter and have sufficient strength to support a body lumen.
Abstract translation: 本公开提供了可生物降解的可植入装置，例如包括可生物降解聚合物的支架，其中处理聚合物材料以控制结晶度和/或Tg。 支架能够在体腔中的体温从卷曲构型扩展到展开的直径，并且具有足够的强度来支撑体腔。
-
公开(公告)号：US20160175288A1
公开(公告)日：2016-06-23
申请号：US15056751
申请日：2016-02-29
Applicant: Elixir Medical Corporation
Inventor： John Yan , Xiaoxia Zheng , Vinayak Bhat
CPC classification number: A61K31/436 , A61K45/06 , A61L29/041 , A61L29/148 , A61L29/16 , A61L31/048 , A61L31/148 , A61L31/16 , A61L2300/41 , A61L2300/416 , A61L2300/42 , A61L2300/426
Abstract: The present invention provides a device for intracorporeal use including an implant or a temporary device and at least one source of a compound myolimus, or a derivative thereof. The present invention also provides a method of inhibiting cell proliferation by local administration of a therapeutically effective amount of a compound myolimus, or a derivative thereof. Further included in the present invention is a method of treating an ophthalmic condition or disease by administering a therapeutically effective amount of a compound myolimus, or a derivative thereof.
Abstract translation: 本发明提供了一种用于体内使用的装置，包括植入物或临时装置和至少一种化合物myolimus的源或其衍生物。 本发明还提供了通过局部施用治疗有效量的化合物肌醇酰胺或其衍生物来抑制细胞增殖的方法。 本发明还包括通过施用治疗有效量的化合物myolimus或其衍生物来治疗眼科疾病或疾病的方法。
-
公开(公告)号：US20160067389A1
公开(公告)日：2016-03-10
申请号：US14945253
申请日：2015-11-18
Applicant: Elixir Medical Corporation
Inventor： Xiaoxia Zheng , John Yan , Vinayak Bhat
CPC classification number: A61L31/14 , A61F2/82 , A61F2/915 , A61F2002/825 , A61F2230/0013 , A61F2250/0036 , A61L31/06 , A61L31/148 , C08G63/08 , Y10T428/13 , Y10T428/1352 , Y10T428/139 , C08L67/04
Abstract: Biodegradable endoprostheses are formed from amorphous polymers having desirable biodegradation characteristics. The strength of such amorphous polymers is enhanced by annealing to increase crystallinity without substantially increasing the biodegradation time.
Abstract translation: 可生物降解的内用假体由具有理想的生物降解特性的无定形聚合物形成。 通过退火来提高这种无定形聚合物的强度以增加结晶度，而基本上不增加生物降解时间。
-
公开(公告)号：US09259339B1
公开(公告)日：2016-02-16
申请号：US14682014
申请日：2015-04-08
Applicant: Elixir Medical Corporation
Inventor： John Yan , Vinayak Bhat
CPC classification number: A61F2/89 , A61F2/915 , A61F2002/91533 , A61F2002/91558 , A61F2002/91575 , A61F2210/0004 , A61F2230/001 , A61F2230/0069 , A61L31/022 , A61L31/06 , A61L31/14 , A61L31/148 , A61L31/16 , A61L31/18 , C08L67/04
Abstract: A biodegradable stent prosthesis formed from a degradable polymeric material, having a plurality of luminal, abluminal, and side surfaces, where at least some of the abluminal surfaces are concave and optionally the side surfaces are convex.
Abstract translation: 由可降解的聚合物材料形成的可生物降解的支架假体，其具有多个管腔，外侧和侧面，其中至少一些所述外侧表面是凹形的，并且可选地所述侧表面是凸形的。
-
公开(公告)号：US20130331927A1
公开(公告)日：2013-12-12
申请号：US13897302
申请日：2013-05-17
Applicant: Elixir Medical Corporation
Inventor： Xiaoxia Zheng , John Yan , Vinayak Bhat
IPC: A61F2/82
CPC classification number: A61F2/915 , A61F2/82 , A61F2/90 , A61F2/91 , A61F2002/91558 , A61F2002/91566 , A61F2002/91575 , A61F2210/0004 , A61F2210/0014 , A61F2210/0019 , A61F2230/0013 , A61F2230/0069 , A61F2240/001 , A61F2250/0073 , A61L31/048 , A61L31/06 , A61L31/14 , A61L31/148 , B33Y80/00 , C08L67/04
Abstract: The disclosure provides biodegradable implantable devices such as a stent comprising a biodegradable polymeric wherein the polymeric material is treated to control crystallinity and/or Tg. The stent is capable to expand at body temperature in a body lumen from a crimped configuration to a deployed diameter and have sufficient strength to support a body lumen.
Abstract translation: 本公开提供了可生物降解的可植入装置，例如包括可生物降解聚合物的支架，其中处理聚合物材料以控制结晶度和/或Tg。 支架能够在体腔中的体温从卷曲构型扩展到展开的直径，并且具有足够的强度来支撑体腔。
-
-
-
-
-
-
-
-
-
Search Results
69
records
(took 0.087 seconds)
